News
In a busy reporting day for biotechs, Orthocell reports promising results of a follow-up study of its nerve repair device Remplir.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback